Boehringer, Lilly diabetes drug shows +ve results
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013
Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III cli...Read more
Indian drugmakers shifting R&D to South East Asia
Generics | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: Many leading Indian drug makers, that comprise a core part of the country's $1,000 bn worth pharmaceutical in...Read more
Unlike FDA, Indian regulators finds no violations at Ranbaxy
Generics | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: India's Drugs Controller General of India (DCGI) has said that under the country's Drugs and Cosmetics Act, i...Read more
Pfizer, Hisun launch generics joint venture in China
Generics | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2012
Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the la...Read more
Teva launches generic of Abilify, antipsychotic drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2015
Singapore: Teva Pharmaceutical has launched the generic equivalent to Abilify, aripiprazole tablets, an atypical antipsy...Read more
Sun's generic of Takeda ulcer drug gets FDA nod
Generics | Regulatory | By BioSpectrum Bureau | 2 Comment | 16 Sep, 2013
Singapore: Indian pharmaceutical major, Sun Pharmaceutical Industries announced that the generic version of Prevacid by ...Read more
Teva to pay $718 mn to apex tax body in Israel
Generics | News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013
Singapore: Israel-based Teva Pharmaceutical is going to pay $718 million to Israel Tax Authority to pay for the release ...Read more
Sandoz gets FDA nod for MS generic drug
Generics | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2015
Singapore: Sandoz, a Novartis company, has recieved USFDA approval of Glatopa, a first generic version of Teva's Copaxon...Read more
Drug shortage forces FDA to approve cancer generic
Generics | News | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2013
Singapore: The US FDA has provided its approval for a generic version of cancer drug Doxil that has been facing shortage...Read more
Hong Kong to host international TCM exhibition, conference
Generics | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...Read more
Britain's MHRA recalls 16 Wockhardt medicines
Generics | Regulatory | By BioSpectrum Bureau | 2 Comment | 12 Jul, 2013
Singapore: UK's drug regulatory body, Medicines and Healthcare products Regulatory Agency (MHRA) has recalled 16 drugs m...Read more
Chinese planning agency to probe pharma prices
Generics | Regulatory | By BioSpectrum Bureau | 2 Comment | 05 Jul, 2013
Singapore: China's primary economic planning agency, the National Development and Reform Commission (NDRC) is in the pro...Read more
Aurobindo recalls epilepsy drug lot in US
Generics | Regulatory | By BioSpectrum Bureau | 2 Comment | 25 Nov, 2014
Singapore: India-based Aurobindo Pharma in the US is recalling Gabapentin capsules, USP 300 mg 100-count bottles, at con...Read more
Wockhardt restructures quality control team
Generics | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2013
Singapore: After being rapped by the US FDA and Indian drug regulator for lapses in good manufacturing practices (GMP), ...Read more
GSK officials under criminal investigation in China
Generics | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013
Singapore: The Chinese police who have been investigating allegations of bribery against senior executives working at UK...Read more
Pneumonia kills a 5-year-old child every 30 secs: UN
Generics | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of...Read more
Sanofi files first-of-a-kind suit against FDA
Generics | News | By BioSpectrum Bureau | 0 Comment | 13 Nov, 2013
Singapore: Sanofi has filed a lawsuit against the US FDA in hopes of preventing the regulatory agency from releasing pac...Read more
“Chinese generics market has no strategy for international playersâ€
Generics | Influencers | By BioSpectrum Bureau | 2 Comment | 17 Nov, 2014
Singapore: In the last one year, Actavis has been aggressive in expanding its presence in Asia and the company was on an...Read more